Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of oxathiazide compound and its use

An oxthiazide and compound technology, applied in the field of innovative chemical drugs, can solve problems in the preclinical research stage or clinical trial stage, etc., and achieve the characteristics of significant drug-like properties, inhibition of receptor desensitization, and reduction of receptor inactivation rate. Effect

Active Publication Date: 2021-03-09
WEST CHINA HOSPITAL SICHUAN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Existing research results have pointed out the direction for the design of AMPA receptor positive allosteric modulators, but most of them are in the preclinical research stage or clinical trial stage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of oxathiazide compound and its use
  • A kind of oxathiazide compound and its use
  • A kind of oxathiazide compound and its use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Compounds disclosed in this example: 8-(4-methoxyphenyl)-4-methyl-3,4-dihydrobenzo[e][1,2,3]oxathiazine 2,2-dioxide ( LT-101)

[0049]

[0050] Concrete synthetic route is as follows:

[0051]

[0052] The specific preparation method is as follows:

[0053] At 0°C, 3-bromo-2-hydroxyacetophenone (A01a) (6.0g, 28mmol) was dispersed in 60ml of dimethylacetamide DMA, and then aminosulfonyl chloride (10g, 86.5 mmol). The reaction system was stirred and slowly raised to room temperature until the reaction was complete. After the reaction, add water to precipitate a solid, filter and wash the filter cake with water and ethyl acetate respectively, and obtain the compound 8-bromo-4-methylbenzo[e][1,2,3]oxathia with a yield of 60%. Azine 2,2-dioxide (A01b).

[0054]Disperse A01b (2.75g, 10mmol) in 50ml of MeOH solvent system, add sodium borohydride (380mg, 10.6mmol) in batches at room temperature, and continue stirring at room temperature until the reaction of raw mate...

Embodiment 2

[0058] Compounds disclosed in this example: 7-(4-methoxyphenyl)-4-methyl-3,4-dihydrobenzo[e][1,2,3]oxathiazine 2,2-dioxide ( LT-102).

[0059]

[0060] Concrete synthetic route is as follows:

[0061]

[0062] The specific preparation method is as follows:

[0063] At 0°C, 4-bromo-2-hydroxyacetophenone (B02a) (6.0g, 28mmol) was dispersed in 60ml of dimethylacetamide DMA, and then sulfamoyl chloride (10g, 86.5 mmol). The reaction system was stirred and slowly raised to room temperature until the reaction was complete. After the reaction, add water to precipitate a solid, filter and wash the filter cake with water and ethyl acetate respectively, and obtain the compound 7-bromo-4-methylbenzo[e][1,2,3]oxathia with a yield of 63%. Oxazine 2,2-dioxide (B02b).

[0064] Disperse B02b (2.75g, 10mmol) in 50ml of MeOH solvent system, add sodium borohydride (380mg, 10.6mmol) in batches at room temperature, and continue stirring at room temperature until the reaction of raw mate...

Embodiment 3

[0068] Compound disclosed in this example: 4-methyl-8-(4-phenoxyphenyl)-3,4-dihydrobenzo[e][1,2,3]oxathiazine 2,2-dioxide (LT-103)

[0069]

[0070] The synthetic route is as in Example 1, replacing "p-methoxyphenylboronic acid" with "4-phenoxyphenylboronic acid".

[0071] MS(ESI)368.1[M+H] + ; 1 H NMR (400MHz, DMSO) δ8.51(s, 1H), 7.49–7.36(m, 6H), 7.31(t, J=7.6Hz, 1H), 7.19(t, J=7.4Hz, 1H), 7.14 –7.04(m, 4H), 4.83(q, J=6.8Hz, 1H), 1.64(d, J=6.9Hz, 3H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of organic synthetic medicine, and specifically relates to an oxathiazine compound, the general formula of which is as follows: the oxthiazine compound can be used as a positive allosteric regulator of AMPA receptors, and it has been confirmed that the compound can positively regulate AMPA receptors can make the conformation of agonists (such as endogenous neurotransmitter glutamate) more stable after binding to receptors, thereby reducing the rate of receptor inactivation and inhibiting receptor desensitization, so that the function of AMPA receptors Can be strengthened, its drug-like property is remarkable, has broad market prospect.

Description

technical field [0001] The invention relates to the technical field of innovative chemical medicines, in particular to an oxathiazide compound and its application. Background technique [0002] AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors are an important subtype of ionotropic glutamate receptors, mainly distributed in the postsynaptic membrane of the central nervous system, Composed of four core subunits G1uR1~4, it mediates the main rapid excitatory transmission in the central nervous system, promotes neural development and outstanding plasticity, and participates in various neural activity processes. Important targets related to systemic diseases. [0003] The extracellular domain of each AMPA receptor subunit contains two domains: the amino-terminal domain (amino-terminal domain, ATD) involved in subunit assembly and the ligand-binding domain (Ligand binding domain, LBD) that provides glutamate binding. Studies have shown that the AMPA ligand b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D291/08C07D419/04A61P25/28A61P25/18A61P25/16A61P25/24A61P25/00A61K31/5415
CPCA61P25/00A61P25/16A61P25/18A61P25/24A61P25/28C07D291/08C07D419/04
Inventor 李涛漆学宇于雪莉
Owner WEST CHINA HOSPITAL SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com